RIG-I-like receptor activation drives type I IFN and antiviral signaling to limit Hantaan orthohantavirus replication

PLoS Pathog. 2020 Apr 24;16(4):e1008483. doi: 10.1371/journal.ppat.1008483. eCollection 2020 Apr.

Abstract

Pathogenic hantaviruses, genus Orthohantaviridae, are maintained in rodent reservoirs with zoonotic transmission to humans occurring through inhalation of rodent excreta. Hantavirus disease in humans is characterized by localized vascular leakage and elevated levels of circulating proinflammatory cytokines. Despite the constant potential for deadly zoonotic transmission to humans, specific virus-host interactions of hantaviruses that lead to innate immune activation, and how these processes impart disease, remain unclear. In this study, we examined the mechanisms of viral recognition and innate immune activation of Hantaan orthohantavirus (HTNV) infection. We identified the RIG-I-like receptor (RLR) pathway as essential for innate immune activation, interferon (IFN) production, and interferon stimulated gene (ISG) expression in response to HTNV infection in human endothelial cells, and in murine cells representative of a non-reservoir host. Our results demonstrate that innate immune activation and signaling through the RLR pathway depends on viral replication wherein the host response can significantly restrict replication in target cells in a manner dependent on the type 1 interferon receptor (IFNAR). Importantly, following HTNV infection of a non-reservoir host murine model, IFNAR-deficient mice had higher viral loads, increased persistence, and greater viral dissemination to lung, spleen, and kidney compared to wild-type animals. Surprisingly, this response was MAVS independent in vivo. Innate immune profiling in these tissues demonstrates that HTNV infection triggers expression of IFN-regulated cytokines early during infection. We conclude that the RLR pathway is essential for recognition of HTNV infection to direct innate immune activation and control of viral replication in vitro, and that additional virus sensing and innate immune response pathways of IFN and cytokine regulation contribute to control of HTNV in vivo. These results reveal a critical role for innate immune regulation in driving divergent outcomes of HTNV infection, and serve to inform studies to identify therapeutic targets to alleviate human hantavirus disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chlorocebus aethiops
  • Cytokines / immunology
  • Cytokines / metabolism
  • DEAD Box Protein 58 / immunology*
  • DEAD Box Protein 58 / metabolism
  • DEAD-box RNA Helicases / metabolism
  • Endothelial Cells / metabolism
  • Hantavirus / immunology
  • Hantavirus / metabolism
  • Hantavirus / pathogenicity
  • Hantavirus / physiology*
  • Hantavirus Infections / immunology*
  • Hantavirus Infections / metabolism
  • Hantavirus Infections / virology
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Immunity, Innate
  • Interferon Type I / immunology*
  • Interferon Type I / metabolism
  • Interferon-beta / metabolism
  • Mice
  • Receptor, Interferon alpha-beta / metabolism
  • Receptors, Immunologic
  • Signal Transduction / immunology
  • Vero Cells
  • Virus Replication / physiology*

Substances

  • Cytokines
  • IFNAR1 protein, human
  • Interferon Type I
  • Receptors, Immunologic
  • Receptor, Interferon alpha-beta
  • Interferon-beta
  • DDX58 protein, human
  • DEAD Box Protein 58
  • DEAD-box RNA Helicases